Why the study?
Does selective or non-selective beta-blockade impair recovery from acute hypoglycaemia in humans?
Does selective or non-selective beta-blockade impair recovery from acute hypoglycaemia in humans?
Non-selective beta-blockade with propranolol impairs the late phase of blood glucose recovery from hypoglycaemia, whereas selective beta-1 blockade with metoprolol has less effect.
Answers are grounded in this paper and cite their sources.
Non-selective beta-blockers warrant caution during hypoglycaemia recovery; leaves open whether this alters outcomes versus selective agents in at-risk patients.
Recovery from acute hypoglycaemia induced by the injection of insulin has been examined in six human subjects under control conditions, under non-selective beta blockade (propranolol) and under selective beta 1 blockade (metoprolol). The normal blood glucose recovery was biphasic with an initial rapid and a slower subsequent phase of recovery. The early recovery mechanism was unaffected by either form of beta blockade, but with propranolol the late phase of recovery was significantly prolonged. Rises in blood lactate and plasma free fatty acids following hypoglycaemia were markedly reduced by propranolol but to a much lesser degree with metoprolol. The counterregulatory hormonal responses of glucagon, cortisol and growth hormone were augmented appropriately for the prolonged hypoglycaemia associated with propranolol. Non-selective beta adrenergic blockade with propranolol is associated with an impairment of the late phase of blood glucose recovery from hypoglycaemia. The possible mechanisms of this impairment are discussed.
No takes yet. Share an insight, caveat, or question.
CORRALL et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: